Dify

Visit website

overall

1,510

out of 60,653

-10

traffic

683

out of 60,653

-4

investment

Not Available

review

702

out of 60,653

These rankings are based on data from December 2025

Company

Dify

Years in business

Number of employees

11-50 employees

Country

United States

Dify.ai is an open-source platform designed for the development and orchestration of generative AI applications, utilizing diverse LLMs for complex workflows and automation, targeting enterprise-level scalability and customization.

API Availability

Pricing

freemium

Go to pricing page

Use

ai agent generation

document generation

workflow automation

workflow management & optimization

Position of Dify on sub rankings

December 2025

Ai agent generation - Overall

11 out of 305

United States - Overall

866 out of 16,681

Workflow automation - Overall

41 out of 1,118

Ai agent generation - Overall

11 out of 305

United States - Overall

866 out of 16,681

Workflow automation - Overall

41 out of 1,118

Industries

education

generic

marketing & sales

software & it

Integrations

anthropic

hugging face

ollama

openai

replicate

Security protocols

soc 2 type 1

Company

Dify

Years in business

Number of employees

11-50 employees

Country

United States

Help us improve this profile

Insights

RankmyAI wants to bring order to the AI chaos, interview with co-founder Jesse Weltevreden

The AI market is growing explosively. New tools appear daily, claims tumble over one another, and anyone trying to keep an overview quickly gets lost. It was precisely in that chaos that Jesse Weltevreden, Professor of Digital Commerce at the Amsterdam University of Applied Sciences, saw a clear societal mission.

Three Roles of AI in Farming: Insights from Top Agrar and RankmyAI

Artificial intelligence has become increasingly common in agriculture, especially in crop production. You hear a lot about technological breakthroughs, but the reality on actual farms is more complicated. Some systems that rely on artificial intelligence are already being used every day, while others are still being tested.